Yachtsman Rob Lewis was diagnosed with prostate cancer after he woke up one morning in excruciating pain.
With his treatment options limited, Lewis was offered a place in a drug trial for advanced cases of prostate cancer."The really remarkable thing as well is this was a treatment he's tolerated really well, it's had minimal side effects," oncologist Dr Megan Crumbaker said."So it's the whole shebang I guess."
During the trial 79 participants were given enzalutamide while 83 were given enzalutamide on top of radiation treatment Lutetium-PSMA-617.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: